, Tracking Stock Market Picks
Enter Symbol:
Mannkind Corporation (MNKD) [hlAlert]

up 57.55 %

Mannkind Corporation (MNKD) downgraded to Hold with price target $11 by MLV & Co

Posted on: Tuesday,  Jul 1, 2014  12:00 AM ET by MLV & Co

MLV & Co rated Hold Mannkind Corporation (NASDAQ: MNKD) on 07/01/2014. Previously MLV & Co rated Buy Mannkind Corporation (NASDAQ: MNKD) on
06/27/2013., when the stock price was $6.55. Since then, Mannkind Corporation has gained 57.56% as of 07/01/2014's recent price of $10.32.
If you would have followed the previous MLV & Co's recommendation on MNKD, you would have gained 57.55% of your investment in 369 days.

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

MLV & Co is a boutique investment bank and institutional broker-dealer focused on providing independent financial advice and unique capital markets expertise to corporate and institutional clients in capital intensive industries such as metals and mining, life sciences, energy and real estate. With a focus on raising money efficiently for clients, MLV has rapidly become a leader in the At-the-Market(ATM) transaction market.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/1/2014 12:00 AM Hold
10.32 11.00
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD up  98.46 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/27/2013 8:25 AM Buy
6.55 8.00
5/15/2013 8:25 AM Buy
4.80 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy